Cambium Networks Corp (CMBMF): Nasdaq/NYSE listing notice — Cambium Networks receives Nasdaq deficiency notice for bid price below $1.00

Cambium Networks Corp

Received deficiency letter on April 10, 2025; bid price below $1.00 for 30 consecutive days.
Must regain compliance by October 7, 2025 via $1.00 close for 10 consecutive business days.
If not compliant, may qualify for additional 180-day period by transferring to Nasdaq Capital Market.
Company may consider reverse stock split but no assurance of regaining compliance.
Shares continue trading on Nasdaq under symbol CMBM; no immediate delisting effect.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Cambium Networks Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

April 10, 2025, Cambium Networks Corporation (“Cambium” or the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Ordinary Shares closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”)

View on SEC.gov

Browse all listing & compliance notices →

Cambium Networks Corp filing history →

Source: SEC EDGAR

accession 0000950170-25-053709

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.